Ranke M B, Price D A, Albertsson-Wikland K, Maes M, Lindberg A
University Children's Hospital, Tübingen, Germany.
Horm Res. 1997;48(2):62-71. doi: 10.1159/000185487.
A total of 195 children (117 males and 78 females) with idiopathic growth hormone deficiency (IGHD) treated with growth hormone (GH) for at least 1 year before puberty onset and who had completed treatment to adult height, were selected from the KIGS database for study of growth during puberty. Spontaneous and induced puberty started at 13.8 and 14.9 years in boys and at 12.9 and 13.7 years in girls, respectively. Duration of GH treatment and height gained prepubertally were greater when puberty was induced; prepubertal catch up growth (expressed as a percentage of the difference between target height and height at start of GH) was greater when puberty was induced in boys (59% induced vs. 45% spontaneous, p < 0.001), and in girls (72% induced vs. 53.9% spontaneous, p < 0.01). Final height was attained at 17.8 and 19.2 years in boys and at 16.0 and 17.0 years in girls following spontaneous and induced puberty, respectively. Final heights were greater after induced puberty compared with spontaneous puberty in boys (171.3 vs. 166.0 cm, p < 0.001) and in girls (157.0 vs. 155.0 cm, n.s.). Target height was also significantly greater in boys with spontaneous puberty (172.2 cm vs. induced = 174.2 cm) as compared to girls (spontaneous = 158 cm vs. induced = 160 cm). Duration of pubertal growth was longer in boys compared to girls (3.6 vs. 3.0 years, p < 0.001) and was negatively correlated with age, height, and distance from target height at onset of puberty, but was not correlated with the dose of GH. Catch-up growth during puberty (expressed as a percentage of the difference between target height and height at puberty onset) after induced and spontaneous puberty was 87.9% and 80.5% (not significant) in boys and 66.4% and 75.5% (not significant in girls. Total pubertal growth (TPG) (cm) was inversely correlated with prepubertal growth by simple linear regression. Multiple linear regression analysis indicated 5 independent predictors of TPG accounting for 78% of the variability, namely sex (boys grew more), distance of target height from height at onset of puberty (+), dose of GH at onset of puberty (+), age at onset of puberty (-), and age at end of growth (+).
从辉瑞全球生长数据库(KIGS)中选取了195名患有特发性生长激素缺乏症(IGHD)的儿童(117名男性和78名女性),这些儿童在青春期开始前接受生长激素(GH)治疗至少1年,并已完成治疗达到成人身高,以研究青春期的生长情况。男孩自然青春期和诱导青春期分别始于13.8岁和14.9岁,女孩分别始于12.9岁和13.7岁。诱导青春期时,GH治疗的持续时间和青春期前获得的身高更大;在男孩中,诱导青春期时青春期前追赶生长(以目标身高与GH开始治疗时身高之差的百分比表示)更大(诱导青春期为59%,自然青春期为45%,p<0.001),女孩中也是如此(诱导青春期为72%,自然青春期为53.9%,p<0.01)。男孩自然青春期和诱导青春期后分别在17.8岁和19.2岁达到最终身高,女孩分别在16.0岁和17.0岁达到最终身高。与自然青春期相比,诱导青春期后男孩的最终身高更高(171.3 vs. 166.0 cm,p<0.001),女孩也是如此(157.0 vs. 155.0 cm,无显著性差异)。自然青春期男孩的目标身高也显著高于女孩(自然青春期男孩为172.2 cm,诱导青春期男孩为174.2 cm;自然青春期女孩为158 cm,诱导青春期女孩为160 cm)。男孩的青春期生长持续时间比女孩长(3.6 vs. 3.0年,p<0.001),且与年龄、身高以及青春期开始时与目标身高的距离呈负相关,但与GH剂量无关。诱导青春期和自然青春期后男孩青春期的追赶生长(以目标身高与青春期开始时身高之差的百分比表示)分别为87.9%和80.5%(无显著性差异),女孩分别为66.4%和75.5%(女孩无显著性差异)。通过简单线性回归分析,青春期总生长(TPG)(cm)与青春期前生长呈负相关。多元线性回归分析表明,TPG的5个独立预测因素解释了78%的变异性,即性别(男孩生长更多)、青春期开始时目标身高与身高的距离(+)、青春期开始时GH剂量(+)、青春期开始年龄(-)以及生长结束时年龄(+)。